Huff James Warren
Chief Executive Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $26.2M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Mar 2, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCChief Executive Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCUnusualSep 27 2019
Sold 63,000 shares at $86.61 ($5.5M)
Huff James Warren, Chief Executive Officer
Sold 40.1% of holdings ($13.6M position)94,157 shares leftFirst sale on recordFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCUnusualNov 10 +410 days
Sold 81,657 shares at $175.01 ($14.3M)
Huff James Warren, Chief Executive Officer
Sold 100% of holdings ($14.3M position)0 shares leftFiling
- 3 Form 4 sale REATA PHARMACEUTICALS INCUnusualMar 2 +842 days
Sold 75,000 shares at $85.46 ($6.4M)
Huff James Warren, Chief Executive Officer
Sold 67.5% of holdings ($9.5M position)36,158 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | REATA PHARMACEUTICALS INC | Chief Executive Officer | Form 4 sale | 75,000 | $6.4M | 67.5% | Unusual | SEC |
| Nov 10, 2020 | REATA PHARMACEUTICALS INC | Chief Executive Officer | Form 4 sale | 81,657 | $14.3M | 100.0% | Unusual | SEC |
| Sep 27, 2019 | REATA PHARMACEUTICALS INC | Chief Executive Officer | Form 4 sale | 63,000 | $5.5M | 40.1% | Unusual | SEC |